174 related articles for article (PubMed ID: 27377395)
1. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
[TBL] [Abstract][Full Text] [Related]
2. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors.
Lavalle GE; De Campos CB; Bertagnolli AC; Cassali GD
In Vivo; 2012; 26(3):375-9. PubMed ID: 22523289
[TBL] [Abstract][Full Text] [Related]
3. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib.
Albanese F; Abramo F; Caporali C; Vichi G; Millanta F
Vet Dermatol; 2013 Dec; 24(6):606-12, e147. PubMed ID: 24128166
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
Tran CM; Moore AS; Frimberger AE
Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412
[TBL] [Abstract][Full Text] [Related]
7. Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
Drag M; Kunkle BN; Romano D; Hanson PD
Vet Ther; 2007; 8(1):41-50. PubMed ID: 17447224
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.
Sonzogni-Desautels K; Knapp DW; Sartin E; Doré M
Vet Comp Oncol; 2011 Sep; 9(3):161-71. PubMed ID: 21848619
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
Marconato L; Lorenzo RM; Abramo F; Ratto A; Zini E
Vet Comp Oncol; 2008 Jun; 6(2):90-101. PubMed ID: 19178668
[TBL] [Abstract][Full Text] [Related]
10. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.
Simon D; Schoenrock D; Baumgärtner W; Nolte I
J Vet Intern Med; 2006; 20(5):1184-90. PubMed ID: 17063714
[TBL] [Abstract][Full Text] [Related]
12. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
Autefage A; Palissier FM; Asimus E; Pepin-Richard C
Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.
DE Campos CB; Lavalle GE; Monteiro LN; Pêgas GRA; Fialho SL; Balabram D; Cassali GD
In Vivo; 2018; 32(6):1659-1666. PubMed ID: 30348731
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
Cunha SC; Corgozinho KB; Souza HJ; Silva KV; Ferreira AM
J Feline Med Surg; 2015 Dec; 17(12):1000-4. PubMed ID: 25673018
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
